000 01492 a2200457 4500
005 20250517042757.0
264 0 _c20160428
008 201604s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-15-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKämmerer, Ulrike
245 0 0 _aTKTL1 expression in human malign and benign cell lines.
_h[electronic resource]
260 _bBMC cancer
_cJun 2015
300 _a2 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCisplatin
_xpharmacology
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aHCT116 Cells
650 0 4 _aHEK293 Cells
650 0 4 _aHeLa Cells
650 0 4 _aHuman Umbilical Vein Endothelial Cells
650 0 4 _aHumans
650 0 4 _aLactic Acid
_xmetabolism
650 0 4 _aMCF-7 Cells
650 0 4 _aPaclitaxel
_xpharmacology
650 0 4 _aRadiation Tolerance
650 0 4 _aTransketolase
_xgenetics
700 1 _aGires, Olivier
700 1 _aPfetzer, Nadja
700 1 _aWiegering, Armin
700 1 _aKlement, Rainer Johannes
700 1 _aOtto, Christoph
773 0 _tBMC cancer
_gvol. 15
_gp. 2
856 4 0 _uhttps://doi.org/10.1186/1471-2407-15-2
_zAvailable from publisher's website
999 _c25086090
_d25086090